- The price of Bio Protocol surged more than 50% after buyers defied broader market selling to push it to $1.46
- Despite wider sell-off pressure, BIO rose double digits in 24 hours while volume jumped 720%
- BIO benefited from key network developments, including staking and new partnerships
On Monday, the price of Bio Protocol (BIO) shrugged off a broader cryptocurrency downturn and led 24-hour gains. The project, which targets the decentralized science (DeSci) ecosystem and recently hit important milestones, attracted renewed buyer interest that sent BIO higher.
BIO price jumps nearly 50% to lead top daily gainers
Bio Protocol’s token posted a sharp rally even as many large-cap altcoins saw profit-taking. While Bitcoin pared gains below $116,000 and Ethereum pulled back toward $4,200, BIO climbed nearly 50% to become one of the strongest performers over 24 hours.
According to CoinMarketCap, the surge placed the DeSci-focused project among the 500 largest cryptocurrencies by market capitalization. The token moved from a low near $0.10 to a high around $0.15 during the rally.
The advance demonstrated BIO’s ability to buck broader market weakness: 24-hour trading volume spiked roughly 720% to more than $393 million. Although BIO remains up in double digits with gains exceeding 21% over the past day, prices cooled off from the $0.15 peak as sellers re-emerged and pushed it back toward $0.12, reflecting persistent market fragility.
Bio Protocol price chart from CoinMarketCap
Network milestones power momentum
Bio Protocol’s recent gains were supported by several meaningful network developments over the past week. As DeSci activity picks up, the Bio team has positioned the project for broader traction with the launch of Bio Markets, a platform designed to provide real-time insights into projects building within the Bio Protocol ecosystem.
Bio Markets aims to surface growth trends and enable in-app trading for participating BioDAOs. The roadmap envisions expanding trading functionality to include IP tokens and newly introduced BioAgents, increasing utility across the ecosystem.
Staking activity rose sharply as well: more than 125 million BIO are currently staked, representing up to 3.5% of circulating supply. The Bio team has highlighted that staking generates BioXP, an important resource required to take part in upcoming Ignition sales.
This week’s app updates also introduced Yapping BioXP and a BioAgent boost campaign intended to further incentivize community engagement. Those features create additional on-chain utility and encourage longer-term participation by holders.
What this means for BIO’s price outlook
Beyond staking and in-app features, Bio Protocol has marked other significant milestones that may support price discovery. The project achieved a milestone with CLAW, the IP-token from Percepta, and Molecule’s development of Bio v2 aims to bridge traditional research institutions with DeSci infrastructure.
Listing on Coinbase, a major U.S.-based exchange, adds a pathway for wider institutional and retail adoption. Bio Protocol summarized recent progress, noting that the launch of Bio V2, more than 100M BIO staked, Coinbase listing, and advances in longevity research helped drive momentum in AI-guided science and DeSci adoption.
These developments—expanded market functionality, growing staking participation, partnerships around IP tokens, and increased exchange visibility—could collectively strengthen BIO’s fundamental case and support future price appreciation. That said, the token’s recent pullback from intraday highs underscores that broader market conditions and profit-taking remain key risks to sustained upside.